278 related articles for article (PubMed ID: 27226584)
1. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
2. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
Chiou JW; Fu B; Chou RH; Yu C
PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
[TBL] [Abstract][Full Text] [Related]
3. Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.
Cho CC; Chou RH; Yu C
Biochem Biophys Res Commun; 2016 Aug; 477(2):188-94. PubMed ID: 27297108
[TBL] [Abstract][Full Text] [Related]
4. Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein.
Katte R; Yu C
PLoS One; 2018; 13(6):e0198767. PubMed ID: 29902210
[TBL] [Abstract][Full Text] [Related]
5. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
6. Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation.
Chang CC; Khan I; Tsai KL; Li H; Yang LW; Chou RH; Yu C
Biochim Biophys Acta; 2016 Nov; 1864(11):1558-69. PubMed ID: 27524699
[TBL] [Abstract][Full Text] [Related]
7. S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.
Khan MI; Su YK; Zou J; Yang LW; Chou RH; Yu C
PLoS One; 2018; 13(2):e0190545. PubMed ID: 29444082
[TBL] [Abstract][Full Text] [Related]
8. S100B as an Antagonist To Interfere with the Interface Area Flanked by S100A11 and RAGE V Domain.
Dowarha D; Chou RH; Yu C
ACS Omega; 2018 Aug; 3(8):9689-9698. PubMed ID: 31459098
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
10. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
[TBL] [Abstract][Full Text] [Related]
11. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain.
Parveen N; Chiu WJ; Shen LC; Chou RH; Sun CM; Yu C
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671465
[TBL] [Abstract][Full Text] [Related]
14. Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis.
Chen Y; Huang M; Yan Y; He D
Bioengineered; 2021 Dec; 12(1):8447-8456. PubMed ID: 34663163
[TBL] [Abstract][Full Text] [Related]
15. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
[TBL] [Abstract][Full Text] [Related]
16. Resonance assignments of Ca²⁺-bound human S100A11.
Hung KW; Chang YM; Yu C
Biomol NMR Assign; 2013 Oct; 7(2):211-4. PubMed ID: 22825890
[TBL] [Abstract][Full Text] [Related]
17. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
18. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
[TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products.
Cecil DL; Johnson K; Rediske J; Lotz M; Schmidt AM; Terkeltaub R
J Immunol; 2005 Dec; 175(12):8296-302. PubMed ID: 16339570
[TBL] [Abstract][Full Text] [Related]
20. The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling.
Teng F; Jiang J; Zhang J; Yuan Y; Li K; Zhou B; Zhou X; Liu W; Zhang P; Liu D; Zheng M; Lu Y; Zhang H
Metabolism; 2021 Apr; 117():154725. PubMed ID: 33571540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
